We are live on ! Find out more
GCM

Geneva Capital Management Portfolio holdings

AUM $4.36B
1-Year Est. Return 17.81%
This Fund
S&P 500
This Quarter Est. Return
+32.58%
1 Year Est. Return
+17.81%
3 Year Est. Return
+59.44%
5 Year Est. Return
+75.65%
10 Year Est. Return
–
AUM
$4.62B
AUM Growth
+$1.1B
Cap. Flow
+$70.8M
Cap. Flow %
1.53%
Top 10 Hldgs %
22.6%
Holding
123
New
3
Increased
67
Reduced
50
Closed
3

Top Buys

Rank Stock Value
1
WDFC icon
WD-40
WDFC
+$18.9M
2
AXON
Axon Enterprise
AXON
+$17.8M
3
ESE icon
ESCO Technologies
ESE
+$12M
4
PLMR icon
Palomar
PLMR
+$11.6M
5
BCPC
Balchem Corp
BCPC
+$10.5M

Top Sells

Rank Stock Value
1
PAYC icon
Paycom
PAYC
+$31.2M
2
MASI
Masimo
MASI
+$25M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$17.8M
4
SXT icon
Sensient Technologies
SXT
+$15.3M
5
MCHP icon
Microchip Technology
MCHP
+$8.38M

Sector Composition

Rank Sector Weight
1 Technology 31.5%
2 Industrials 21.87%
3 Healthcare 19.11%
4 Consumer Discretionary 8.67%
5 Financials 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HEI.A icon
101
HEICO Corp Class A
HEI.A
$37.2B
$3.98M 0.09%
48,991
-781
-2% -$60.6K
MSFT icon
102
Microsoft
MSFT
$3.71T
$3.91M 0.08%
19,231
+171
+0.9% +$31K
ADBE icon
103
Adobe
ADBE
$105B
$3.86M 0.08%
8,868
-938
-10% -$348K
PAYC icon
104
Paycom
PAYC
$9.69B
$3.62M 0.08%
11,676
-117,335
-91% -$31.2M
DHR icon
105
Danaher
DHR
$144B
$3.54M 0.08%
22,595
+204
+0.9% +$29.3K
GOOGL icon
106
Alphabet (Google) Class A
GOOGL
$4.33T
$3.46M 0.07%
48,780
+480
+1% +$32.4K
V icon
107
Visa
V
$677B
$3.36M 0.07%
17,408
+155
+0.9% +$28.3K
TMO icon
108
Thermo Fisher Scientific
TMO
$220B
$3.22M 0.07%
8,881
+79
+0.9% +$26.5K
CRM icon
109
Salesforce
CRM
$158B
$3.03M 0.07%
16,165
+144
+0.9% +$24.3K
ATVI
110
DELISTED
Activision Blizzard
ATVI
$2.89M 0.06%
38,061
+336
+0.9% +$23.4K
LOW icon
111
Lowe's Companies
LOW
$125B
$2.69M 0.06%
19,943
+175
+0.9% +$20K
COST icon
112
Costco
COST
$420B
$2.5M 0.05%
8,263
+73
+0.9% +$22.2K
ECL icon
113
Ecolab
ECL
$79.9B
$2.48M 0.05%
12,478
+111
+0.9% +$21.5K
TJX icon
114
TJX Companies
TJX
$178B
$2.41M 0.05%
47,606
+428
+0.9% +$21.5K
EW icon
115
Edwards Lifesciences
EW
$51.7B
$2.34M 0.05%
33,825
+300
+0.9% +$21.3K
IWO icon
116
iShares Russell 2000 Growth ETF
IWO
$15.1B
$2.09M 0.05%
10,117
-17,311
-63% -$3.24M
DIS icon
117
Walt Disney
DIS
$181B
$1.78M 0.04%
16,009
-2,826
-15% -$312K
VFC icon
118
VF Corp
VFC
$5.89B
$1.55M 0.03%
25,399
+227
+0.9% +$13.2K
IWP icon
119
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$512K 0.01%
6,476
-4,100
-39% -$297K
MKTX icon
120
MarketAxess Holdings
MKTX
$5.72B
$295K 0.01%
+588
New +$274K
EWBC icon
121
East-West Bancorp
EWBC
$18B
– –
-141,951
Closed -$3.65M
LGND icon
122
Ligand Pharmaceuticals
LGND
$6.36B
– –
-392,416
Closed -$17.8M
SXT icon
123
Sensient Technologies
SXT
$5.53B
– –
-352,482
Closed -$15.3M
1 2 3 4
5

Similar funds

SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
EQF
Evergreen Quality Fund Grand Cayman, Cayman Islands $4.37B AUM 119.42% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
FIS
Fundsmith Investment Services Grande Riviere Noire, Mauritius $4.41B AUM 6.68% 1-Year Est. Return
CFO
Callan Family Office Radnor, Pennsylvania $4.41B AUM 26.21% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Geneva Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geneva Capital Management held 123 positions worth $4.62B, up 31% from $3.52B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 4.9%. Geneva Capital Management opened 3 new positions and exited 3, leaving the 123-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

  • Geneva Capital Management's largest Q2 2020 buy was Axon Enterprise: 220,073 shares worth $21.6M.
  • Geneva Capital Management added most to WD-40 in Q2 2020, an estimated $18.9M increase.
  • Geneva Capital Management's biggest Q2 2020 reduction was Paycom, cutting an estimated $31.2M.
  • Geneva Capital Management fully exited Ligand Pharmaceuticals in Q2 2020, selling an estimated $17.8M.
  • Geneva Capital Management's ten largest holdings make up 23% of its $4.62B portfolio in Q2 2020.
  • Geneva Capital Management opened 3 new positions and closed 3 in Q2 2020.
  • Geneva Capital Management's portfolio value rose 31% quarter-over-quarter to $4.62B.

Based on Geneva Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.